Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:32
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 50 条
  • [41] Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
    Yang, Hang
    Almadani, Noorah
    Thompson, Emily F.
    Tessier-Cloutier, Basile
    Chen, Julia
    Ho, Julie
    Senz, Janine
    McConechy, Melissa K.
    Chow, Christine
    Ta, Monica
    Cheng, Angela
    Karnezis, Anthony
    Huvila, Jutta
    McAlpine, Jessica N.
    Gilks, Blake
    Jamieson, Amy
    Hoang, Lynn N.
    MODERN PATHOLOGY, 2023, 36 (06)
  • [42] Utility of p16 andHPVtesting in oropharyngeal squamous cell carcinoma: An institutional review
    Abdelhakam, Dina A.
    Huenerberg, Katherine A.
    Nassar, Aziza
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (01) : 54 - 59
  • [43] Effect of p16 Status on Survival Outcomes in Sinonasal Squamous Cell Carcinoma
    Agarwal, Aarti
    Philips, Ramez
    Chitguppi, Chandala
    Gargano, Stacey
    Sahin, Ziver
    Curry, Joseph
    Luginbuhl, Adam
    Cognetti, David
    Toskala, Elina
    Rabinowitz, Mindy R.
    Rosen, Marc R.
    Nyquist, Gurston G.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2023, 132 (08) : 917 - 925
  • [44] Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy
    Li, Li
    Fukumoto, Manabu
    Liu, Duo
    ONCOLOGY LETTERS, 2013, 6 (06) : 1611 - 1615
  • [45] Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients
    Taghavi, Noushin
    Biramijamal, Firouzeh
    Sotoudeh, Masoud
    Moaven, Omeed
    Khademi, Hooman
    Abbaszadegan, Mohammad Reza
    Malekzadeh, Reza
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (39) : 4958 - 4967
  • [46] Performance analysis of Leica Biosystems p16 monoclonal antibody in oropharyngeal squamous cell carcinoma
    Thavaraj, Selvam
    Robinson, Max
    Dayal, Shubham
    Bowen, Claire
    DIAGNOSTIC PATHOLOGY, 2025, 20 (01)
  • [47] Are Histomorphological Features Predictive of p16 Immunopositivity Different for Oral and Oropharyngeal Squamous Cell Carcinoma?
    Gayatree, Aishwary
    Tanveer, Nadeem
    Arora, Vinod Kumar
    Arora, Vipin
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2020, 11 (02) : 248 - 255
  • [48] Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma
    Ferreira, Chrystiano de C.
    Dufloth, Rozany
    de Carvalho, Ana C.
    Reis, Rui M.
    Santana, Iara
    Carvalho, Raiany S.
    Gama, Ricardo R.
    PLOS ONE, 2021, 16 (06):
  • [49] Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva
    Hay, Casey M.
    Lachance, Jason A.
    Lucas, F. L.
    Smith, Kahsi A.
    Jones, Michael A.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (03) : 252 - 256
  • [50] Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma
    Dixon, Peter R.
    Au, Michael
    Hosni, Ali
    Perez-Ordonez, Bayardo
    Weinreb, Ilan
    Xu, Wei
    Song, Yuyao
    Huang, Shao Hui
    O'Sullivan, Brian
    Goldstein, David P.
    de Almeida, John R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (09): : 1347 - 1353